KIP Infrastructure
2.27.3 -
This page is part of the KIP Infrastructure (v2.27.3: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: https://kip.rkkp.dk/fhir/ValueSet/Immunoterapi | Version: 2.27.3 | |||
| Active as of 2022-07-18 | Computable Name: Immunoterapi | |||
Immunoterapi
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
This value set includes codes based on the following rules:
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues version 📦2.27.3| Code | Display | Definition |
| none | Ingen immunoterapi | None - used to choose none of the available values |
https://kip.rkkp.dk/fhir/CodeSystem/ATC version 📦2.27.3
| Code | Display | Definition |
| L01FA01 | Rituximab | L01FA01 - rituximab |
| L01FA03 | Obinutuzumab | L01FA03 - obinutuzumab |
| L01FA02 | Ofatumumab | L01FA02 - ofatumumab |
| L04AA | MabCampath | L04AA - Selective immunosuppressants |
| L01FX05 | Brentuximab vedotin (Adcetris) | L01FX05 - brentuximab vedotin |
| L01FX14 | Polatuzumab incl evt. Rituximab | L01FX14 - polatuzumab vedotin |
| L01FF | PD(L)1 hæmmere | L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified version 📦2.27.3
| Code | Display | Definition |
| glofitamab | Glofitamabel Epcoritamab Incl evt. Rituximab | Glofitamab |
Expansion performed internally based on:
This value set contains 9 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues | none | Ingen immunoterapi | None - used to choose none of the available values | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FA01 | Rituximab | L01FA01 - rituximab | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FA03 | Obinutuzumab | L01FA03 - obinutuzumab | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FA02 | Ofatumumab | L01FA02 - ofatumumab | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L04AA | MabCampath | L04AA - Selective immunosuppressants | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FX05 | Brentuximab vedotin (Adcetris) | L01FX05 - brentuximab vedotin | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FX14 | Polatuzumab incl evt. Rituximab | L01FX14 - polatuzumab vedotin | ||
https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01FF | PD(L)1 hæmmere | L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors | ||
https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified | glofitamab | Glofitamabel Epcoritamab Incl evt. Rituximab | Glofitamab |